Cysteamine prodrugs, pharmaceutical compositions thereof, and methods of use
US9630917B2 · kind B2 · utility
1Cited by
0References
16Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 19, 2015 |
| Grant date | Apr 25, 2017 |
| Priority date | — |
| Expiry date | Sep 19, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2601/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Cysteamine prodrugs, pharmaceutical compositions comprising the cysteamine prodrugs, and methods of using cysteamine prodrugs and pharmaceutical compositions thereof for treating eye, kidney, liver, metabolic, and neurological disorders such as cystinosis, cystinuria, non-alcoholic steatohepatitis, Batten disease, Leigh syndrome, and Huntington's disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.